PRFX Reports Preclinical Results
PRF Technologies reports expanded preclinical results for PRF-110, showing comparable analgesic efficacy to ZYNRELEF
PRFX - PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved BenchmarkAdditional data reported by an independent research firm show comparable analgesic efficacy to ZYNRELEF alongside slower absorption and enhanced local tissue retention, reinforcing PRF-110's potential as a long-acting, single-administration post-operative analgesic